Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
Open Access
- 15 September 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
Abstract
The COVID-19 pandemic represents an unprecedented challenge for the researchers to offer safe, tolerable, and effective treatment strategies for its causative agent known as SARS-CoV-2. With the rapid evolution of the pandemic, even the off-label use of existing drugs has been restricted by limited availability. Several old antivirals, antimalarial, and biological drugs are being reconsidered as possible therapies. The effectiveness of the controversial treatment options for COVID-19 such as nonsteroidal antiinflammatory drugs, angiotensin 2 conversion enzyme inhibitors and selective angiotensin receptor blockers was also discussed. A systemic search in the PubMed, Science Direct, LitCovid, Chinese Clinical Trial Registry, and ClinicalTrials.gov data bases was conducted using the keywords “coronavirus drug therapy,” passive immunotherapy for COVID-19’, “convalescent plasma therapy,” (CPT) “drugs for COVID-19 treatment,” “SARS-CoV-2,” “COVID-19,” “2019-nCoV,” “coronavirus immunology,” “microbiology,” “virology,” and individual drug names. Systematic reviews, case presentations and very recent clinical guidelines were included. This narrative review summarizes the available information on possible therapies for COVID-19, providing recent data to health professionals.This publication has 177 references indexed in Scilit:
- Integrated safety in tocilizumab clinical trialsArthritis Research & Therapy, 2011
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLoS Pathogens, 2010
- BevacizumabThe Oncologist, 2010
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple SclerosisClinical Neuropharmacology, 2010
- ThalidomideThe Lancet, 2004
- SildenafilDrugs, 1999
- LeflunomideDrugs, 1999
- AzithromycinDrugs, 1996
- AzithromycinDrugs, 1992
- RamiprilDrugs, 1990